Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Files An 8-K Regulation FD Disclosure

ME Staff 8-k
-
0
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Files An 8-K Regulation FD Disclosure

Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

Beginning on December4, 2018, Osmotica Pharmaceuticals plc intends to use the presentation furnished herewith, or portions thereof, in one or more meetings or presentations with investors and analysts. The presentation will also be available online at https://ir.osmotica.com/events-presentations as of December4, 2018. A copy of the presentation is furnished as Exhibit99.1.

The information contained in this Current Report on Form8-K, including Exhibit99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibits

Exhibit No.

Description

99.1

Investor Presentation


Osmotica Pharmaceuticals plc Exhibit
EX-99.1 2 a18-41074_1ex99d1.htm EX-99.1 Exhibit 99.1 Investor Presentation / December 2018   1 Safe Harbor This presentation contains forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. All statements other than statements of historical facts contained in this presentation,…
To view the full exhibit click here